Arcus Biosciences (RCUS) Enterprise Value (2017 - 2025)
Arcus Biosciences (RCUS) has 9 years of Enterprise Value data on record, last reported at -$981.0 million in Q4 2025.
- For Q4 2025, Enterprise Value changed N/A year-over-year to -$981.0 million; the TTM value through Dec 2025 reached -$981.0 million, changed N/A, while the annual FY2025 figure was -$981.0 million, N/A changed from the prior year.
- Enterprise Value reached -$981.0 million in Q4 2025 per RCUS's latest filing, down from -$831.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$156.0 million in Q2 2024 and bottomed at -$1.2 billion in Q1 2022.
- Average Enterprise Value over 5 years is -$856.8 million, with a median of -$920.5 million recorded in 2023.
- Peak YoY movement for Enterprise Value: soared 83.23% in 2024, then plummeted 483.97% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$499.0 million in 2021, then crashed by 102.2% to -$1.0 billion in 2022, then rose by 24.78% to -$759.0 million in 2023, then tumbled by 43.48% to -$1.1 billion in 2024, then increased by 9.92% to -$981.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$981.0 million in Q4 2025, -$831.0 million in Q3 2025, and -$911.0 million in Q2 2025.